Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03744260 · ClinicalTrials.gov registry record
Medial Branch Radiofrequency Ablation and Lumbar Multifidi
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 4
- Enrollment target
NCT03744260: Completed study, sponsored by Columbia University.
NCT03744260 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03744260 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of lumbar medial branch radiofrequency ablation (RFA) on lumbar multifidi muscle size and clinical spinal stability. Specifically, this study is designed to highlight the comparison of multifidi muscle architecture using ultrasound imaging (USI) and MRI before and after lumbar medial branch RFA. This study will also include a commonly utilized functional assessment of the lumbar spine to evaluate the effects of RFA on lumbar spinal stability.
Primary Outcome
Analysis will include volumetric measurements of the multifidi as well as volumetric assessments of the muscle with fat subtracted.
Interventions
- DIAGNOSTIC_TEST Patients undergo ultrasound and lumbar MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2020-06-30 |
What the finished NCT03744260 record still lists
NCT03744260 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patients undergo ultrasound and lumbar MRI is the first listed.
NCT03744260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03744260 about?
NCT03744260 is a clinical study titled "Medial Branch Radiofrequency Ablation and Lumbar Multifidi". The purpose of this study is to evaluate the effects of lumbar medial branch radiofrequency ablation (RFA) on lumbar multifidi muscle size and clinical spinal stability. Specifically, this study is designed to highlight the comparison of multifidi muscle architecture using ultrasound imaging (USI) a...
What is the current status of trial NCT03744260?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2017-01-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03744260?
The interventions under investigation include: Patients undergo ultrasound and lumbar MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03744260?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI